Testing the Potential of High-dose Vitamin B6 Supplements for Sensory Reactivity in Autism
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:
• Between the ages of 18 to 60
• With a diagnosis of autism
Locations
Other Locations
United Kingdom
University of Reading
RECRUITING
Reading
Contact Information
Primary
Dr David T Field, PhD
d.t.field@reading.ac.uk
+441183785004
Backup
Alex Cameron, MSc
a.cameron@pgr.reading.ac.uk
Time Frame
Start Date: 2024-11-08
Estimated Completion Date: 2025-10
Participants
Target number of participants: 40
Treatments
Experimental: Vitamin-B6
Participants will consume one high-dose Vitamin B6 100 mg tablet orally once daily for one month. Vitamin B6 will be provided as Pyridoxal-5'-Phosphate (PLP)
Placebo_comparator: Placebo
Participants will consume a Placebo tablet matching the appearance of the Vitamin B6 tablets in the Experimental arm orally once daily for one month.
Related Therapeutic Areas
Sponsors
Leads: University of Reading
Collaborators: INNOPURE